Dose Finding Safety Study of VAL201 in Cancer Patients

Clinical trial NCT02280317 · COMPLETED

Trial details

NCT number: NCT02280317
Sponsor: ValiRx Plc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage III Prostate Carcinoma Stage IV Prostate Carcinoma

Start date: 2014-10-01
Primary completion: 2020-01-27
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.